David Cordani - Feb 22, 2023 Form 4 Insider Report for Cigna Group (CI)

Role
Chairman & CEO, Director
Signature
Kevin Ciaglo, attorney-in-fact
Stock symbol
CI
Transactions as of
Feb 22, 2023
Transactions value $
$0
Form type
4
Date filed
2/24/2023, 08:12 PM
Previous filing
Jan 11, 2023
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +10.9K +9.7% $0.00 123K Feb 22, 2023 Direct F1
holding CI Common Stock, $.01 Par Value 1.7K Feb 22, 2023 By 401(k) F2
holding CI Common Stock, $.01 Par Value 377K Feb 22, 2023 By GRAT
holding CI Common Stock, $.01 Par Value 90.5K Feb 22, 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +40.1K $0.00 40.1K Feb 22, 2023 Common Stock, $.01 Par Value 40.1K $294.61 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in three equal annual installments beginning March 1, 2024.
F2 Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
F3 This option vests in three equal annual installments beginning March 1, 2024.